FDA warns Lifetech Resources on eyelash enhancement claims

04/27/2011 | CosmeticsDesign.com

Marketing campaigns for eyelash cosmetics RapidLash Eyelash Renewal Serum, NeuLash Eyelash Technology and NeuveauBrow Active Eyebrow Technology violate the U.S. Food, Drug, and Cosmetic Act because they contain a drug and claim to make physiological differences which cosmetics are not allowed to do, according to an FDA warning letter.

View Full Article in:

CosmeticsDesign.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA